BEIJING, Sept. 22, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, ...

In the assessment of 12-month price targets, analysts unveil insights for Collegium Pharmaceutical, presenting an average ...

As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...

The third quarter was a pivotal period for both the biotech and pharmaceutical sectors, with regulatory developments and an increase in business deals shaping the landscape for the industries. Public ...

TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (QNTM) (FRA: 0K91) (“Quantum BioPharma”), is pleased to announce that national television network CTV News’ flagship investigative ...

The MarketWatch News Department was not involved in the creation of this content. BOSTON, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical ...

The Company is now in full compliance with all Nasdaq continued listing requirements and the Company's common stock will remain listed and traded on the Nasdaq Stock Market.

TORONTO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and ...

As of Thursday, February 12, Connect Biopharma Holdings Limited’s CNTB share price has dipped by 5.85%, which has investors questioning if this is right time to buy.

Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) reported Q4 CY2025 results , with sales up 17% year on year to $874.6 ...

The MarketWatch News Department was not involved in the creation of this content. MELBOURNE, Australia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) ("Propanc" or the ...

Taking cognisance of the fact that India's disease burden is shifting toward non-communicable diseases such as diabetes, cancer and autoimmune disorders, Union finance minister Nirmala Sitharaman ...